Bradford S Goodwin
CIK 1293633 · Chairperson of the Board · last filed 2021-05-21
Bradford S Goodwin is a Chairperson of the Board who has filed 39 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for RIGL, was dated May 21, 2021. Across all open-market trades the lifetime net is +$99.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $199.4K across reported positions. 10 SEC filings were submitted jointly with PDL BIOPHARMA, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RIGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 3,500 | $46.72 | $163.5K | $99.3K | 16 | 2021-05-21 |
| FACT | Director | 3,334 | $10.75 | $35.8K | $0 | 3 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Chairperson of the Board | — | — | — | $0 | 6 | 2008-07-17 |
| COTHERIX INC (CTRX) Delisted | Director | 0 | — | — | $0 | 2 | 2007-01-10 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-21 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2020-05-15 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2019-05-24 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2018-05-18 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2017-05-12 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2016-05-12 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2015-05-14 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2013-05-28 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2012-06-11 | — | Grant (A) | — | $0 | |
| 2012-05-24 | RIGL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.